OraSure Technologies to Present at Needham & Company, LLC Growth Conference
BETHLEHEM, Pa.--(BUSINESS WIRE)--Jan. 4, 2006--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Needham & Company, LLC Growth Conference in New York City. The conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on January 10, 2006, at approximately 11:30 am Eastern Time (8:30 am Pacific Time). Interested investors can access the live audio webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the audio webcast will be available on OraSure Technologies' web site for seven days. Alternatively, you can access the live audio webcast of the presentation via the following link http://www.wsw.com/webcast/needham13/osur.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pa., the company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. For more information on the Company, please go to www.orasure.com.
CONTACT: OraSure Technologies, Inc.
Ronald H. Spair, 610-882-1820
Investorinfo@orasure.com
SOURCE: OraSure Technologies, Inc.
